SeaKing Solace markSEAKINGSOLACE
Open navigation

The product development roadmap

An ambitious destination. A disciplined development pathway.

Five intended stages connect our precision-motion platform vision to the work needed for clinical reality. Early R&D supplies the measurements that guide software and engineering; subsequent work must establish technical performance, safety, and clinical effectiveness.

Fund the WorkExplore the current R&D scope
Current status

Concepts and engineering design. Phase 1 planning.

Five intended stages

Build with purpose. Advance with evidence.

01
Current R&D priority · Study in planning

Physiological characterization

The proposed Phase 1 SAIL study begins with natural vessel motion in healthy adults. It is intended to characterize the motion participants receive, synchronize physiological measurements, and assess the consistency and interpretation of response patterns.

Intended development output
A characterized motion-and-physiology dataset, candidate signals, and measurement requirements to inform the platform's engineering.
Requirements for progression
Data quality, reproducibility, competing explanations, and scientific interpretation determine which findings can responsibly guide the next stage.
02
Planned development stage

Engineering calibration

Use characterized motion and validated findings to inform controlled stimulus delivery, sensor integration, synchronization, operating limits, and system design. Controlled reproduction is part of calibrating and evaluating the engineering approach.

Intended development output
Evidence-informed engineering requirements and a defined approach to repeatable motion delivery and monitoring.
Requirements for progression
Technical performance, measurement reliability, and the ability to reproduce selected inputs and evaluate responses must be demonstrated.
03
Planned development stage

Prototype and protocol development

Integrate motion delivery, physiological sensing, and software. Evaluate usability, tolerability, and response differences, including whether individualized approaches are technically and physiologically justified.

Intended development output
A progressively refined prototype and candidate protocols suitable for appropriately governed evaluation.
Requirements for progression
Engineering verification, risk assessment, feasibility, and the evidence supporting candidate protocols guide progression.
04
Future stage · Evidence and approvals required

Clinical validation

Develop appropriate studies with clinically relevant populations and outcomes. Autism-specific investigations would require their own study design, participant protections, and applicable approvals.

Intended development output
Clinical evidence addressing defined uses, meaningful outcomes, risks, and the people for whom an approach may be suitable.
Requirements for progression
Physiological response alone is insufficient: safety and clinical benefit must be evaluated directly.
05
Long-term objective · Conditional on validation

Clinical translation and commercialization

Address applicable regulatory requirements, quality and manufacturing needs, implementation models, clinician workflows, and access. The route will depend on the eventual device and intended use.

Intended development output
A potential path from validated technology to a deployable clinical product.
Requirements for progression
Required evidence, applicable authorizations, operational feasibility, and funding must support proceeding. Commercialization is not assured.

The current program, in context

Phase 1 is the foundation for product engineering.

What the first study contributes

Characterized natural motion and synchronized physiological data to inform software, system design, and the next engineering decisions. The proposed participants are healthy adults.

Review the Phase 1 study →

What later development must establish

Controlled delivery, technical verification, candidate protocols, and clinical evidence for defined uses. Autism-specific studies require separate development and applicable approvals.

Explore potential clinical pathways →

Build what comes next

An ambitious destination. A defined way forward.

Explore philanthropy, investment, and sponsorship to find the funding path that fits you.

Fund the WorkExplore development milestones